CIK 0001434647 · Non-accelerated filer<br>Smaller reporting company
ZEVRA THERAPEUTICS, INC.
Sign in to watch- Ticker
- ZVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 205894398
- Phone
- (888) 958-1253
- Business address
- 101 FEDERAL STREET, BOSTON, MA, 02110
- Former names
- KEMPHARM, INC, KEMPHARM INC
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chief Legal & Compliance sold 1,794 shares at $11.30 ($20,272)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Option exercise Director acquired 78,400 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 144 Insider Sale of Securities
- 8-K Event Material agreement · Agreement ended · Regulation FD disclosure
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations · Executive or director change
- 4 Planned sale President and CEO sold 14,625 shares at $8.56 ($125,186)
Page 2 of 44 · 870 filings